Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 386

The DOI matches its Crossref record.

Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer

Berry, Donald A., Cronin, Kathleen A., Plevritis, Sylvia, Fryback, Dennis G., Clarke, Lauren, Zelen, Marvin, Mandelblatt, Jeanne S., Yakovlev, Andrei Y., Habbema, J Dik F., Feuer, Eric·2006·Obstetrical & Gynecological Survey

Abstract

In several countries, a drop in mortality from breast cancer has been documented starting in 1975. Both early detection by mammographic screening and advances in management are plausible explanations. The National Institutes of Health have used a competitive peer review process to develop 7 independent statistical models of breast cancer incidence and mortality. A consortium of investigators used the same sources to obtain data on screening mammography, adjuvant treatment, and health benefits relating to the rate of death from breast cancer in the years 1975–2000. The use of mammographic screening in women age 40 and over increased markedly over the period 1985 to 2000. The use of adjuvant treatment depended on numerous factors beside the calendar year, including age, tumor stage, and estrogen-receptor status. The proportion of women given adjuvant treatment increased from virtually none in 1975 to approximately 80% in 2000. By 2000, half of all women were using tamoxifen. All 7 models predicted similar proportional reductions in mortality from a combination of screening and adjuvant therapy. The proportion of overall reduction in breast cancer deaths ascribed to screening ranged from 28% to 65% (median, 46%). The remaining decrease in mortality was associated with adjuvant treatment. Variation between models in the absolute contribution of screening was greater than for treatment. Combined screening and adjuvant therapy reduced breast cancer mortality by 25 to 38% (median, 30%). The proportion of decreased mortality ascribed to adjuvant treatment was 12 to 21% (median, 19%). For each of the 7 models, the combination of screening and adjuvant treatment lowered mortality slightly less than the sum of contributions from screening and adjuvant therapy alone. The investigators conclude from these findings that both mammographic screening and adjuvant treatment have helped to lower deaths from breast cancer in the United States.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.ogx.0000201966.23445.91

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 386

Metadata

Authors
Berry, D. A., Cronin, K. A., Plevritis, S., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E.
Venue
Obstetrical & Gynecological Survey
Published
2006-03
Volume
61
Issue
3
Pages
179-180
ISSN
0029-7828 (ISSN-L)
OpenAlex
W1980576430
Cited by
386
References
0
FWCI
22.94
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer. https://app.cochat.ai/papers/10.1097/01.ogx.0000201966.23445.91
The paper
Berry, D. A., Cronin, K. A., Plevritis, S., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. (2006). Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer. Obstetrical & Gynecological Survey. https://doi.org/10.1097/01.ogx.0000201966.23445.91

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.